T

Tongling Jieya Biologic Technology Co Ltd
SZSE:301108

Watchlist Manager
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Watchlist
Price: 26.76 CNY -5.31% Market Closed
Market Cap: 2.2B CNY
Have any thoughts about
Tongling Jieya Biologic Technology Co Ltd?
Write Note

Tongling Jieya Biologic Technology Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tongling Jieya Biologic Technology Co Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
T
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Operating Income
ÂĄ105.3m
CAGR 3-Years
-22%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Operating Income
ÂĄ4.2B
CAGR 3-Years
-10%
CAGR 5-Years
-5%
CAGR 10-Years
0%
Proya Cosmetics Co Ltd
SSE:603605
Operating Income
ÂĄ1.7B
CAGR 3-Years
41%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Operating Income
ÂĄ807.3m
CAGR 3-Years
8%
CAGR 5-Years
21%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Operating Income
ÂĄ2B
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Operating Income
ÂĄ1.7B
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Tongling Jieya Biologic Technology Co Ltd
Glance View

Market Cap
2.2B CNY
Industry
Consumer products

Tongling Jieya Biologic Technology Co., Ltd. engages in the research and development, production, and sale of wet wipes. The company is headquartered in Tongling, Anhui and currently employs 798 full-time employees. The company went IPO on 2021-12-03. The firm's main businesses are the research and development, production and sales of sanitary products. The firm's wet wipes products include baby series, adult functional series, antibacterial disinfection series, household cleaning series, medical care series and pet cleaning series. The firm is also engaged in the production of facial masks.

Intrinsic Value
22.97 CNY
Overvaluation 14%
Intrinsic Value
Price
T

See Also

What is Tongling Jieya Biologic Technology Co Ltd's Operating Income?
Operating Income
105.3m CNY

Based on the financial report for Dec 31, 2023, Tongling Jieya Biologic Technology Co Ltd's Operating Income amounts to 105.3m CNY.

What is Tongling Jieya Biologic Technology Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
11%

Over the last year, the Operating Income growth was -27%. The average annual Operating Income growth rates for Tongling Jieya Biologic Technology Co Ltd have been -22% over the past three years , 11% over the past five years .

Back to Top